Keywords
glaucoma, betaxolol, timolol, b-blockers
Abstract
Despite the progress of ophthalmology, the treatment of glaucoma remains one of the most important problems in this area of medicine. Traditionally, the main place in the treatment of glaucoma is taken by drug therapy. Thanks to the progress of pharmacology, the arsenal of antiglaucoma drugs has significantly replenished. However, a large selection of drugs creates certain difficulties for the practitioner: it is becoming increasingly difficult to understand the huge flow of scientific and advertising information about new drugs. This review aims to summarize the results of the most important experimental and clinical studies on betaxolol, one of the most effective treatments for glaucoma.